Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Drugmaker reports on expanding pipeline of oncology and supportive care compounds
January 5th, 2006
GlaxoSmithKline, plc, (GSK) updated investors and financial analysts in New York City, New York on the company's expanding pipeline featuring science that addresses a broad range of patient needs for cancer prevention, treatment, and supportive care. The seminar "clearly shows the progress GSK has made in building its oncology pipeline," said Tachi Yamada, GSK's chairman of research & development. "From modest beginnings, we now have a pipeline which is one of the largest in our industry with seven major assets expected to be in phase III development in the coming months, including the four NCEs [new chemical entities] highlighted" in the seminar. ...
Source: Women's Health Weekly (2006-01-05)
|
